News & Events

News & Events Home

Aristopharma and Sanofi Bangladesh Limited signed Bilateral Agreement

A bilateral agreement on manufacturing high tech products had been signed on 5th June, 2016 between Aristopharma Ltd. and Sanofi Bangladesh Ltd. During the Signing Ceremony, on behalf of Aristopharma Ltd., Chairman & Managing Director Mr. M. A. Hassan along with other directors and high ranking officers and on behalf of Sanofi Bangladesh Ltd., Managing Director Dr. Riad Mamun Prodhani and other directors were present.
 

Other News

Aristopharma introduces AROMATIN tablet for the women with breast cancer

Breast cancer is the most common cancer in women in Bangladesh. For the postmenopausal women with breast cancer, Aristopharma has recently introduced Aromatin film coated tablet. It is a preparation of Anastrozole USP 1 mg. Even after breast cancer surgery, the biosynthesis of estrogen (Aromatization) has to be stopped to prevent the recurrence of estrogen receptor positive (ER+) breast cancer in postmenopausal women. Anastrozole is highly effective and safe non-steroidal aromatase inhibitor which can stop the conversion of androgen into estrogen (the process called aromatization). Hence, it can strongly prevent the recurrence of breast cancer. Anastrozole can be used as adjuvant, first line and second line treatment option for breast cancer. It is safe for renal and hepatic impaired patients. The dose is- 1 tablet per day and the price is affordable.

Aristopharma’s Dedicated Cephalosporin Plant has started operation

Aristopharma has started operation of its new Dedicated Cepha Plant located at Gachha, Gazipur and Axim 250 Tablet has rolled out as the 1st product from this plant in June 2016. Phase by phase all of its cephalosporin products – tablet, capsule, suspension & injections- would be supplied from this dedicated cephalosporin plant. This plant has set up under supervision of globally esteemed Rob Walker Consultancy Ltd. of UK and as per the standard of WHO cGMP & UK MHRA. With the finely tuned layout, world class machinery, dedicated Effluent Treatment Plant (ETP) and above all higher skilled & experienced manpower, this plant is going to be one of the best of its kind in the country.

Xibra is now renamed as Etovan

Aristopharma recently has changed brand name of its Etoricoxib preparation from Xibra to Etovan. Etovan is available in 3 strengths- Etovan 60, 90 & 120 mg tablet. The significance of new brand name is “Etovan: Etoricoxib – The marvelous analgesic”. The design of blister & carton has been changed as the consequence of brand name change. However the top quality of the raw materials as well as the finished products would remain unchanged and would offer the same clinical result as previous. The company believes that this new brand name would be more acceptable to the doctors.

Aristopharma Helds Annual Sales Conference-2015

Aristopharma, one of the leading pharmaceutical companies of Bangladesh, helds its Annual Sales Conference on December 30, 2015 at International Convention City, Bashundhara, Dhaka. The company started its operation in 1986 and in 2016 it would step into its 30th year of glorious journey. Currently Aristopharma ranks as one of the top 10 companies in overall Pharma market & no.1 position in the Ophthalmic market of Bangladesh. Moreover, it also exports medicines to around 25 countries of the world and is moving to expand its export market. The Chairman & Managing Director, Mr. M. A. Hassan, thanked all his employees for their united efforts which have brought the company to its current position. Other Directors & Senior Managers also shared strategies for future development of the company. Around two thousand people working in different parts of the country attended the conference. Awards were given to the achievers in different categories.

Aristopharma introduces Laczym Chewable Tablet for the people who can not digest milk

Aristopharma has recently introduced First Time in Bangladesh Laczym chewable tablet, the preparation of lactase 9000 IU. Lactose present in milk is digested by an enzyme called “Lactase”. Normally lactase remains in human body, but many people fail to produce adequate lactase to digest lactose. They experience gas, bloating, diarrhea, abdominal cramp etc while taking milk & milk products. Laczym Chewable Tablet would be a blessing for this group of people. From now onwards they would be able to take milk & milk product comfortably if they take 1 Laczym Chewable Tablet before milk. Because Laczym Tablet contains that natural enzyme Lactase, which is required to digest milk & milk products. It’s a very safe drug. In fact worldwide Lactase is considered as a dietary supplement, not as a drug. It works naturally and can be used by everyone aged 4 years and above. It is suggested to chew 1 tablet before taking any milk product. If needed 2 tablets can be taken at a time. Laczym Chewable Tablet can be used every day and every time before taking milk and milk products.

Aristopharma conducts Raffle Draw of World Cup Cricket Quiz

The renowned pharmaceutical company of Bangladesh, Aristopharma arranged Optimox Quiz for doctors during ICC Cricket World Cup -2015. A large number of doctors participated in this quiz competition. The Raffle Draw of this Quiz was held on 13 May 2015 at the Principal Office of Aristopharma. Eminent cricket commentator Shamim Ashraf Chowdhury and player of Bangladesh national cricket team, Imrul Kayes conducted this Raffle Draw. The Chairman & Managing Director of Aristopharma, Mr. M. A. Hassan, other Directors and high officials of the company were present in this Raffle Draw program.

Aristopharma introduces coral calcium with the brand name of Fossical-D

Aristopharma recently introduces Fossical-D, the preparation of calcium (derived from coral fossil) USP 500 mg & vitamin D3 BP 200 IU tablet. Coral fossil is the natural source of calcium derived from fossilized coral reefs. Apart from calcium, it also contains magnesium and more than 70 other trace minerals. In coral fossil, calcium and all these trace minerals form a natural matrix which resembles almost similar to human bone matrix & gives better absorption of calcium. Moreover, due to the presence of magnesium it causes less constipation which is a common drawback of conventional calcium preparations. Thus Fossical-D ensures better bone, teeth & brain development and many other health benefits than conventional calcium preparations. Fossical-D is also superior to calcium orotate. The amount of elemental calcium is only 40 mg in 400 mg tablet and 85 mg in 740 mg tablet which do not meet the body requirement of calcium. But Fossical-D contains 500 mg calcium in each tablet. Fossical-D is formulated with USA origin raw material which is FRIEND OF THE SEA certified and no Genetically Modified Organisms (GMO) has been used to manufacture Fossical-D.

Aristopharma held Annual Sales Conference-2014

Aristopharma, one of the leading pharmaceutical companies of Bangladesh held its Annual Sales Conference at Hotel Sea Palace, Cox’s Bazar. Aristopharma holds the no. 8 position in the overall pharma market & no. 1 position especially in ophthalmic category of Bangladesh. Moreover, it also exports medicines to 25 countries of the world. In his speech the Chairman & Managing Director of the company, M. A. Hassan thanked his employees to bring the company to this position. Other Directors & Senior Managers also spoke on the occasion and gave strategies for future development. Around 2000 people working in different parts of the country attended the conference. Awards were given to the achievers in different categories.

Raffle Draw of FIFA World Cup-2014 on Optimox held by Aristopharma

The renowned pharmaceutical company of Bangladesh, Aristopharma and its ophthalmic division, Aristovision arranged Optimox Quiz for doctors during FIFA World Cup Football-2014. A large number of doctors participated in this quiz competition. The Raffle Draw of this Quiz was held on 4 September 2014 at the Principal Office of Aristopharma. The captain of the Shadhin Bangla Football Team and eminent football organizer, Mr. Jakaria Pintu conducted this Raffle Draw. The Chairman & Managing Director of Aristopharma Mr. M. A. Hassan, other Directors and high officials of the company were present at this Raffle Draw program.

Aristopharma introduces Optimox Tablet - A New Hope for Treatment Success

Aristopharma recently introduces Optimox, the preparation of Moxifloxacin 400 mg tablet. Moxifloxacin is a 4th generation fluoroquinolone. It is approved by US FDA for RTIs, Sinusitis, SSTIs & Intra-abdominal infections. It is also effective for TB, endocarditis, pelvic inflammatory disease etc. Antibiotic resistance is a common problem in our country as many common antibiotics like amoxicillin, ciprofloxacin, cefuroxime, azithromycin etc. are becoming resistant against many bacteria. As the chance of resistance to Optimox is very rare- 1in a Billion and Optimox is highly effective in multidrug resistant cases, it can be a better alternative to these drugs in these indications. Optimox is also better than gemifloxacin in terms of efficacy, tolerability and treatment cost. The safety profile is better than other fluoroquinolones. It is safe for renal and hepatic impaired patients. The dose is simple- 1 tablet per day and the price is also affordable, thus Optimox tablet offers less treatment cost than commonly used antibiotics as well.

Image Gallery

© 2017. Aristopharma Ltd. All rights reserved.
Site by DIGITA iNTERACTIVE

HOME | PRODUCTS | FACILITIES | GLOBAL PRESENCE | NEWS | ABOUT US | CONTACT | CAREER

Webmail
Bookmark and Share